Carillon Tower Advisers released its Q2 2024 investor letter discussing the performance of the Carillon Eagle Mid Cap Growth Fund, highlighting stocks like DexCom, Inc. and emphasizing the potential of AI stocks for higher returns. DexCom, Inc.